Tumors of the pleura
Malignant pleural mesothelioma
Mesothelioma is quite a rare disease and for this reason there are no screening programs for the early diagnosis in persons not at risk. In the case of persons exposed to asbestos for longer or shorter periods, some doctors recommend periodic examinations (X-ray or Computed Tomography) to monitor any changes over time in the structure of the lungs that might indicate the presence of mesothelioma or lung cancer. However it is not yet clear whether this strategy could lead to early diagnosis.
The best way to prevent mesothelioma is to avoid or at least minimise the exposure to asbestos. New laws require the verification of the presence of asbestos in public buildings such as schools, but there may also be traces of this material in older homes. It is important to contact professional technicians who will check construction materials and remove the parts that are not up to standard. DIY removal should be avoided, since bad work may cause the risk of contaminating other areas of the house and the inhalation dangerous fibres.
Symptoms of the malignant pleural mesothelioma
The symptoms of mesothelioma are initially non-specific and they are often ignored or interpreted as signs of other more common and less severe diseases. Early signs of pleural mesothelioma may include pain in the lower back or side of the chest, shortness of breath, cough, fever, fatigue, weight loss, difficulty swallowing, muscle weakness. Abdominal pain, weight loss, nausea and vomiting are more common symptoms of peritoneal mesothelioma.
Test for diagnosing malignant pleural mesothelioma
The first step for a proper diagnosis remains a visit to the general practitioner or a specialist, inquiring about medical history to determine whether there has been exposure to asbestos and assessing the presence of fluid in the abdomen or in the cavity around the heart. In cases of suspected mesothelioma, more specific tests will be carried out.
- Chest CT with contrast medium is used to determine the presence of the tumour, its exact location and the possible spread to other organs, and assist the surgeon in deciding the type of intervention. A spiral CT has recently been developed that is faster and allows for more detailed images compared to the traditional one.
- PET is used to identify the cells that are growing faster and correspond to cancer cells. The images obtained are not as detailed as those of the TC but may help doctors understand whether the abnormalities of the mesothelium are actually tumours or lesions of other kinds and whether the cancer has spread to lymph nodes or other parts of the body. Today, there are tools that can perform both CT and PET in a single session.
- Biopsy is the most effective tool to confirm a suspected mesothelioma. In some cases fluid samples are obtained from the chest (thoracentesis), abdomen (paracentesis) or the cavity around the heart (pericardialcentesis) using a long thin needle to ascertain the presence of cancer cells under a microscope. In other cases, it is necessary to withdraw small portions of mesothelial tissue with a thin needle inserted under the skin or with the insertion of a probe equipped with a video camera through a small cut in the skin. This way, the doctor can see the suspicious areas and take the samples to be then analysed under the microscope. To distinguish mesothelioma from other types of tumour with certainty, samples taken by biopsy may be subjected to immune-histochemical assays (to see the proteins present on the surface of the cell) or genetic assays (to detect the expression of genes typical of mesothelioma). Blood tests are not typically used to arrive at diagnosis, but it may be useful to confirm a diagnosis obtained with other techniques or to follow up the evolution of the disease during and after treatment. In particular, levels of osteopontin and SMRP are measured, as those molecules are present in higher concentration in case of mesothelioma.
Solitary fibrous tumor of the pleura: symptoms and test for diagnosis
This variant of the pleural tumour has a mostly silent course and it is often diagnosed by chance through a simple imaging test. The bigger the mass size the more likely and severe the symptoms are: shortness of breath, chest pain and cough are three recurrent symptoms in patients with pleural fibrous tumour. Less frequently, however, patients suffering from this form of pleural cancer may complain of anorexia, chills, fever, haemoptysis, swelling of the lower limbs, paraneoplastic manifestations (osteoarthropathy and hypoglycaemia by overproduction of the Insulin-like growth factor II), syncope and pleural effusion. In the giant forms hypomobility of the hemithorax affected by the neoplasia may be encountered.
Fibrous tumour of the pleura is often diagnosed by chance via a simple radiological investigation performed for other reasons. Among the diagnostic strategies aimed at ascertaining tumour of the pleura: routine blood tests, upper abdomen ultrasonography, CT scan, chest CT and MRI, are included. A few patients have to undergo a further examination, PET, which is useful in selected subjects with a suspected malignant degeneration of the tumour.
Mediastinal cancers
Thymic cancers
Because of its painless course, the diagnosis of thymoma can often be random. At least 30% of patients are asymptomatic at the time of diagnosis. When the often very vague and hazy symptoms are present, they are due to local compression or infiltration of surrounding structures. The most common are chest pain, cough, dyspnoea, paralysis of a hemidiaphragm through phrenic nerve involvement, but dysphonia may also be present through infiltration of the recurrent nerve and signs relating to superior vena cava syndrome.
Thymomas may be associated with a number of paraneoplastic syndromes: the most frequent is without doubt Myasthenia Gravis, which is present in 30-45% of patients, while pure red cell aplasia and hypogammaglobulinaemia occur in 2-5% of cases.
Hypogammaglobulinaemia is present in 2-5% of patients with thymoma A. Thymoma A rarely develops distant metastases, however in some cases it may be locally-invasive with infiltration of surrounding organs and spread to the parietal pleura and/or pericardium. The degree of local invasiveness is decisive in the choice of treatment.
A CT scan of the chest is needed to determine the extent of the lesion, the relationship with adjacent structures and possible pleural and/or pericardial effusions. It can also be instrumental in diagnosing small tumours not appreciable with a standard chest X-ray. Surgical biopsy of the lesion is not recommended in cases of encapsulated thymic tumours because of the risk of dissemination; it is necessary in the case of unresectable tumours or for differential diagnosis with other malignant neoplasms affecting the anterior mediastinum for a correct therapeutic choice.
Neuromas
In the majority of cases, these are detected occasionally with chest radiography. The test used to diagnose this disease with certainty is a chest CT scan, to which a spinal MRI might be added, in cases of suspected extension to the spinal canal.
Oesophageal cancers
Precautions to prevent cancers of the oesophagus
Avoiding alcohol and smoking are the main precautions to prevent the formation of squamous cell oesophageal cancer. Regarding adenocarcinoma, in the majority of cases it develops from a Barrett's Oesophagus, so the most effective way to prevent this is reducing the risk of gastro-oesophageal reflux. This is achieved by reducing the consumption of coffee, alcohol and cigarettes and avoiding being overweight and obesity. Although several antacid drugs are able to control the symptoms of reflux, scientific demonstrations of their efficacy in reducing the appearance of Barrett's Oesophagus are not available so far.
Tests for the early diagnosis of the tumors of esophageal cancers
There are no screening tests in healthy patients, but early diagnosis is extremely important once Barrett's Oesophagus has developed in order to catch the possible malignant transformation quickly. In patients where the oesophageal mucosa has turned into gastric mucosa, endoscopy is recommended every two or three years. In patients whose transformed cells show signs of abnormality (dysplasia), it is recommended to repeat endoscopy at least two times every six months and then once a year. Finally, if the degree of dysplasia is high (that is if the cells are highly transformed), endoscopic removal or even surgery is recommended, because this is a precancerous condition at high risk of malignant transformation.
Symptoms of oesophageal cancer
Almost always, initial symptoms of oesophageal cancer are progressive loss of weight preceded by dysphagia, that is difficulty in swallowing, which usually appears gradually first with solid foods and after with liquids. These symptoms are reported by 90 percent of patients. In addition, growth of the tumour to the outside of the oesophagus can lead to a decrease or an alteration in the tone of the voice because it involves nerves that govern the emission of sounds, or induce paralysis of the diaphragm, or even a pain in the chest just behind the breastbone, if the area between the heart, lungs, sternum and spine is involved.
In the most advanced stages of the cancer, the ability to take food may be reduced. If the tumour is ulcerated, swallowing may become painful. When the mass of the tumour impedes the descent of the food down the oesophagus, regurgitation episodes may occur. In more advanced forms, the lymph nodes on the sides of the neck and above the collarbone can swell, or liquid can form in the lining of the lung (pleural effusion) with the onset of dyspnea (difficulty breathing), or even bone pain may appear or an increase in size of the liver. The cause of these symptoms is usually related to the presence of metastases.
Diagnostic tests for oesophageal cancer
In symptomatic patients, diagnostic strategy includes an X-ray of the oesophagus with contrast medium and oesophageal endoscopy (oesophagogastroscopy) that allows us to see whether there is a lesion and obtain material for analysis of the cells. The combination of the two procedures increases the diagnostic sensitivity to 99 per cent. X-rays are used to exclude the presence of associated disease, the oesophagogastroscopy is the examination with the greatest diagnostic value because it allows direct visualisation of the structures and to take samples for biopsy.
Echo-endoscopy is another type of test that allows us to determine more accurately how deep the infiltration of the layers in the oesophageal wall is, and can point out lymph nodes that are suspicious for metastatic involvement. Once the tumour has been localised, to complete the diagnostic testing it is appropriate to perform chest CT abdomen with contrast medium and PET in order to exclude the presence of remote metastases.
.
Nutritional prevention for the tumors of the esophagus
Based on careful evaluation of the results from current scientific research, it has been possible to identify specific risk factors and protective nutritional factors for specific types of cancer. Experts have classified the results into four levels: "convincing evidence", "probable evidence", "limited evidence" and one last level that collects the effects for which evidence of association with the cancer is “highly unlikely." The probable and convincing evidence for the basis of the recommendations are:
Risk Factors
- alcoholic beverages (convincing evidence)
- being overweight and obesity (convincing evidence for adenocarcinoma).
Protective factors
- fruit and vegetables
- foods rich in beta-carotene, such as carrots, pumpkin, apricots, spinach, sweet and spicy peppers (probable evidence)
- foods rich in vitamin C, such as citrus fruit juice peel, kiwi, strawberries, sweet and spicy peppers (evidence likely).